The Centers for Medicare and Medicaid Services (CMS) announced a final rule for the Sunshine Act on Feb. 1 that will increase public disclosure of financial relationships between drug and device manufacturers and physicians and teaching hospitals.
The latest version of the American College of Radiology’s (ACR) Liver Imaging Reporting and Data System (LI-RADS) — a system of standardized terminology and criteria to interpret and report imaging examinations of the liver — includes several modifications and enhancements to the previous version. These include:
A prospective study was published recently in the American Journal of Roentgenology on whether coronary computed tomography angiography (CTA) provided an accurate and efficient management method for assessment of chest pain patients with low to intermediate risk of acute coronary syndrome (ACS). This study, presented by Ricardo C. Cury, M.D., of Baptist Health of South Florida, current vice president of the Society of Cardiovascular Computed Tomography (SCCT) and colleagues, was carried out over three emergency departments in a large healthcare system, between January 2009 and October 2010, and found that length of stay was cut in half, and the rate of major adverse cardiac events (MACE) remained very low in patients with negative CTA findings.
While most women understand the importance of health screenings, an estimated 72 million have missed or postponed a ...
A new computed tomography (CT) scanner substantially reduces potentially harmful radiation while still improving overall image quality. National Institutes of Health (NIH) researchers, along with engineers at Toshiba Medical Systems, worked on the scanner. An analysis of data on 107 patients undergoing heart scans found that radiation exposure was reduced by as much as 95 percent compared to the range of current machines, while the resulting images showed less blurriness, reduced graininess and greater visibility of fine details.
At an exclusive event scheduled March 1, 2013, Elekta will reveal a leap forward in radiation oncology and the care of individuals with cancer worldwide.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
The need for flawless coordination of its carbon ion treatments led officials at the CNAO Foundation (Centro Nazionale di Adroterapia Oncologica) to choose Elekta’s Mosaiq Oncology Information Management System. On Nov. 13, the CNAO Foundation became the world’s first center to use Mosaiq to guide a cancer patient’s carbon ion therapy. CNAO — which made news last year when it treated its first patient with proton therapy — is now nearing completion of its National Center of Oncological Hadrontherapy.
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
Agfa HealthCare has introduced its global remote incident prevention (GRIP) services to provide state-of-the-art electronic monitoring of all IMPAX picture archiving and communication systems (PACS) worldwide, as well as linked devices from other suppliers. GRIP’s ultimate goal is to prevent unsettling downtime surprises in the healthcare environment.
PhysioSonics announced the U.S. Food and Drug Administration (FDA) has granted the Presto 1000 Flow Monitor system 510(k) clearance for cranial blood flow monitoring. In addition, the company announced completion of Series B add-on debt financing, closing with $1.05 million.
February 1, 2013 — SoftVue, the whole breast ultrasound device created by two scientists from the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine, is currently undergoing review by the U.S. Food and Drug Administration (FDA) for market clearance.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
A patient's relationship with his or her doctor has long been considered an important component of healing. Now, in a novel investigation in which physicians underwent brain scans while they believed they were actually treating patients, researchers have provided the first scientific evidence indicating that doctors truly can feel their patients' pain — and can also experience their relief following treatment.
February 1, 2013 — Six clinical trials, including one evaluating the effectiveness of proton beam therapy in treating children with specific brain cancers and three proton therapy trials for men with prostate cancer, are being led by researchers at CDH Proton Center, A ProCure Center.
Accu-Tatt is an easy-to-use, sterile, all inclusive tattooing device designed to permanently mark radiation therapy patients. Every Accu-Tatt pouch conveniently contains an ink ampoule and a ¾-inch, 22-gauge needle. Packaging the needle and ampoule in a sterilized pouch reduces the concern for contamination and cross-contamination within radiation therapy facilities. In addition, Accu-Tatt’s short needle length allows for increased control while tattooing the patient. The Accu-Tatt shell contains an ampoule filled with sterile black ink. To start the flow of ink, hold the ampoule upright in one hand and use the thumb to bend the shell, breaking the ampoule. The end of the ampoule houses a luer lock fitting to accommodate the prepackaged, sterilized hypodermic needle.
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Analogic Corp. is acquiring Ultrasonix Medical Corp., a supplier of ultrasound systems for point-of-care and general imaging applications. Ultrasonix has more than 5,000 systems installed worldwide, and would bring key ultrasound products, technology and sales channels that are complementary to Analogic's ultrasound business.
In what one day may be recognized as a melding of epidemiology and medical imaging, researchers are associating human conditions once viewed as unavoidable or natural consequences of American life as diseases with commonalities that can be seen and measured in the living brain.
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Matakina International announced that the Volpara objective breast density measurement software will be used in the European Union (EU) collaborative Adapting Breast Cancer Screening Strategy Using Personalised Risk Estimation (ASSURE) research project.
Fujifilm Medical Systems U.S.A. Inc. shared the benefits of its zero footprint mobile application, Synapse Mobility, with visitors to the 2012 meeting of the Radiological Society of North America (RSNA). The application enables access to Fujifilm’s suite of Synapse products from hand-held devices, in addition to Macintosh- or Windows-based PCs. It was one of several Synapse products and solutions demonstrated at the show.
Samsung Electronics America, Inc., a subsidiary of Samsung Electronics Co. Ltd, announced its acquisition of NeuroLogica, a leading computed tomography (CT) company headquartered in Danvers, Massachusetts. Established in 2004, NeuroLogica develops cutting-edge medical imaging products and is known for its world-class portable CT scanners, such as BodyTom and CereTom. Terms of the deal were not disclosed.
In a study designed to see if doctors who are told the exact price of expensive medical tests like magnetic resonance imaging (MRI) in advance would order fewer of them, Johns Hopkins researchers got their answer: No.
Varian Medical Systems has received a U.S. Food and Drug Administration (FDA)- 510(k) clearance for the latest version of its Vitesse real time planning for HDR brachytherapy which is used to plan and perform high-dose-rate (HDR), ultrasound-guided brachytherapy treatments for prostate cancer.
Avreo announced the release of Version 7.4 for preview at HIMSS 2013. Version 7.4 enhancements include voice recognition improvements such as voice command shortcuts, advanced report template management and new voice recognition editor workflow to offer interpreting physicians the option to send voice recognition reports to an editor for final review prior to distribution.